MedTrace Logo

Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

NCT06322537 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 505

Last updated 2025-11-26

No results posted yet for this study

Summary

All heart surgery patients universally require hydration, which is given through a vein in the arm, but practices for treating patients are not universal. There are disagreements about whether crystalloids should be used alone or in combination with albumin. This question has important implications because albumin is an expensive blood product in relatively limited supply, and 20% of its use is by heart surgery patients. The goal of this study is to learn more about how crystalloids and albumin are used during heart surgery, as well as, key patient outcomes.

Conditions

  • Cardiovascular Surgical Procedures
  • Albumin

Sponsors & Collaborators

  • Kingston Health Sciences Centre

    collaborator OTHER

  • Unity Health Toronto

    collaborator OTHER

  • McMaster University

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    collaborator OTHER

  • London Health Sciences Centre

    collaborator OTHER

  • The Ottawa Hospital

    collaborator OTHER

  • Vancouver General Hospital

    collaborator OTHER

  • Royal Columbian Hospital Foundation

    collaborator OTHER

  • Nova Scotia Health Authority

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Keyvan Karkouti, MD MSc FRCPC · Toronto General Hospital - University Health Network

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-23
Primary Completion
2025-12-01
Completion
2026-01-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06322537 on ClinicalTrials.gov